News · Agriculture & Food Systems
Ayana Bio and Zenfold buy Meati's fermentation equipment
By Startup Enthusiast ·
- Date
- Company
- Ayana Bio
- What it does
- Plant cell culture ingredients startup
- Kind
- News
- Amount
- $75,000
- Based in
- Boston
What they do
Ayana Bio is a Boston startup that grows plant cells in bioreactors to make high-value ingredients
What happened
It jointly bought 12 fermentation tanks from bankrupt Meati Foods for $75,000 with Zenfold Sustainable Technologies
Why it matters
The equipment will be shipped to India to set up a pilot facility for plant cell development by early 2027
The details
- Ayana Bio and Zenfold Sustainable Technologies jointly bought Meati Foods' fermentation equipment for $75,000.
- The equipment includes 12 fermentation tanks, each 25,000 litres, plus seed trains, totalling 300,000 litres of capacity.
- The equipment was originally worth several million dollars when installed at Meati's Colorado facility.
- Meati Foods entered an Assignment for the Benefit of Creditors (ABC) process in May 2025 and laid off most staff by end of 2025.
- Meati was later acquired by Meati Holdings, but its core fermentation assets remained unsold in an online auction in spring 2026.
- Ayana Bio and Zenfold will decommission and ship the equipment to Zenfold's facilities in India.
- The equipment will establish a dedicated Ayana Bio pilot facility for plant cell development, with a target operational date of first half of 2027.
- The pilot capabilities will also be accessible to other plant cell companies.
The bigger picture
- Plant cell culture grows plant cells in bioreactors under controlled conditions to produce high-value compounds and secondary metabolites.
- Advantages include consistent supply despite climate change, no pesticides, reduced land and water use, and higher yields.
- The 25,000-litre fermenters provide an intermediate scale between pilot and Zenfold's existing 100,000-litre commercial runs, reducing technical and financial risk.
- Ayana Bio's initial target ingredients include rosmarinic acid from sage, which is seen as a natural preservative alternative amid proposed bans on synthetic preservatives like BHA.
About the business
- Ayana Bio is a Boston-based startup focused on plant cell culture to produce high-value ingredients.
- It grows plant cells in bioreactors under controlled conditions to make compounds like rosmarinic acid, crocins, zeaxanthin, and lutein.
- Initial target ingredients are rosmarinic acid from sage, crocins from saffron, and zeaxanthin and lutein from marigold.
- Rosmarinic acid is positioned as a natural preservative alternative amid regulatory activity against synthetic preservatives.
- Zenfold Sustainable Technologies is headquartered in Bengaluru with manufacturing and R&D in Bengaluru and Hyderabad.
- Zenfold focuses on specialty and fine chemicals using green chemistry, biotransformation, and synthetic biology.
- Zenfold already operates four 100,000-litre bioreactors.
What happens next
- Ayana Bio and Zenfold will decommission and ship the equipment to Zenfold's facilities in India.
- The equipment will establish a dedicated Ayana Bio pilot facility for plant cell development.
- The pilot facility is targeted to be operational by the first half of 2027.
- The pilot capabilities will also be accessible to other plant cell companies.
The deal
- Type
- asset purchase
Founders
- Frank Jaksch, CEO
Other articles talking about it
Same day
- NODWIN Gaming launches NODWIN Sports division15 September 2026 · Launch
- Dot & Key launches Dragon Fruit Bounce Jelly Moisturiser15 September 2026 · Launch
- Moneyview cuts IPO size, early backers reduce stake15 September 2026 · Analysis · ₹750 Cr
- Motilal Oswal deploys Zoho enterprise platform to unify records15 September 2026 · Partnership
- Firi raises $3M seed for beauty quick commerce15 September 2026 · Funding · $3M
- Inc42 features five emerging AI startups15 September 2026 · Analysis